Cargando…
Molecular dynamics simulations and functional studies reveal that hBD-2 binds SARS-CoV-2 spike RBD and blocks viral entry into ACE2 expressing cells
New approaches to complement vaccination are needed to combat the spread of SARS-CoV-2 and stop COVID-19 related deaths and long-term medical complications. Human beta defensin 2 (hBD-2) is a naturally occurring epithelial cell derived host defense peptide that has antiviral properties. Our comprehe...
Autores principales: | Zhang, Liqun, Ghosh, Santosh K., Basavarajappa, Shrikanth C., Muller-Greven, Jeannine, Penfield, Jackson, Brewer, Ann, Ramakrishnan, Parameswaran, Buck, Matthias, Weinberg, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805467/ https://www.ncbi.nlm.nih.gov/pubmed/33442698 http://dx.doi.org/10.1101/2021.01.07.425621 |
Ejemplares similares
-
HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19
por: Zhang, Liqun, et al.
Publicado: (2022) -
Trimeric receptor-binding domain of SARS-CoV-2 acts as a potent inhibitor of ACE2 receptor-mediated viral entry
por: Basavarajappa, Shrikanth C., et al.
Publicado: (2022) -
Expression of Human β-defensin 2 (hBD-2) in Pichia Pastoris and Investigation of Its Binding Efficiency with ACE-2
por: Çobanoğlu, Şeymanur, et al.
Publicado: (2023) -
hBD-2 is downregulated in oral carcinoma cells by DNA hypermethylation, and increased expression of hBD-2 by DNA demethylation and gene transfection inhibits cell proliferation and invasion
por: KAMINO, YOSHITAKA, et al.
Publicado: (2014) -
The expression of the β-defensins hBD-2 and hBD-3 is differentially regulated by NF-κB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis
por: Steubesand, Nadine, et al.
Publicado: (2009)